Summary
Overview
Work History
Education
Skills
Affiliations
Certifications And Registrations
Awards And Appointments
Publications And Papers
Lectures And Speaker Engagements
Addresses
Personal Information
Timeline
Generic

Regina Ponder

Summary

Dedicated and adaptable professional with a proven track record. Proactive attitude with the ability to "think on her feet" and value-added contributions. Strong work ethic and effective collaborative communication skills. Years of hands-on industry and academic experience in the healthcare research and academic industries. Eager to contribute to the bottom line while moving a "status quo" organization into greater sustainability.

Overview

40
40
years of professional experience

Work History

Contractor; Life Sciences, Research and Mathematics Instruction

Greater Metropolitan College Preparatory Charter Schools
01.2017 - 12.2025
  • 2017 -2025: Contracted as a life sciences, research, and mathematics instructor at Greater Metropolitan College Preparatory Charter Schools, collaborating with various academic institutions.
  • Instructed at Eagle Mountain College Prep (2019-2020), Arts Academy, Scottsdale (2016-2017), Paragon Science Academy (2017-2018), Chandler, Arizona State University Preparatory Academy (Chemistry) Phoenix (2022-2024), Basis Phoenix (Biology/Clinical Research) (2024-2025), and Academy of Math & Science (ELA/Humanities) (2025-2026).
  • Executed daily responsibilities with precision and care.
  • Contributed innovative ideas and solutions to enhance team performance and outcomes.
  • Worked successfully with a diverse group of coworkers to accomplish goals and address issues related to our products and services.

Clinical Research Program Director/Faculty

Maricopa Community Colleges
01.2013 - 12.2016
  • 2013-2016: Clinical Research Program Director/Faculty – Maricopa
  • Community Colleges
  • -Developed Syllabus and overall program structure for ‘Good Clinical Practice’ (GCP) Clinical Research
  • Coordinator and Clinical Research Associate Courses Programs; Programs Approved by the
  • Maricopa Community College Governing Board; Oversaw community internship student placement, facilitating practical experience for students in clinical research settings

Faculty/Lecturer

GateWay Community College
01.2015 - 12.2016
  • 2015-2016: Maricopa Community Colleges; GateWay Community College
  • Faculty/Lecturer – Introduction to Healthcare for Allied Health Professionals Course; Delivered curriculum and administered grades for new students entering allied health fields.
  • Developed inclusive course materials that addressed the needs of diverse student populations, promoting accessibility and engagement.
  • Facilitated interactive classroom discussions that encouraged critical thinking and enhanced overall student learning experiences.
  • Evaluated student performance through assignments and examinations.

Regional Based CRA

PRA Health Sciences
05.2016 - 02.2017
  • May 2016 – Feb 2017: Regional Based CRA
  • Provided clinical research support and monitored adult vaccine trial in southwest US; managed TMF data entry; participated in ongoing FDA regulated procedural monitoring and GCP courses; performed remote case report form data entry; conducted investigative site visits and safety reporting.
  • Home Office based.

Consultant Clinical Research Coordinator – Medical Devices

Valley Urogynecology Associates
05.2015 - 01.2016
  • May 2015 – Jan 2016: Consultant Clinical Research Coordinator – Medical Devices
  • Medical Device Clinical Trial Lead with a Boston based Medical Device Company.
  • Ensured compliance with clinical research certification and industry standards, contributing to study integrity.
  • Trained investigative site staff to execute study deliverables effectively, enhancing team readiness.
  • Conducted pre-enrollment and enrollment Study Subject interviews, case report form completion, and data entry.
  • Monitored and tracked device inventory, ensuring accountability and facilitating seamless study operations. and Western Institutional Review Board (WIRB) submissions.

Clinical Research Director and Educator

GateWay Community College
01.2012 - 05.2016
  • Jan 2012 – May 2016: Clinical Research Director and Educator
  • Instructed Health Science students and developed Good Clinical Practice research-based curriculum for clinical research programs: Study Coordinators and Clinical Research Monitors, enhancing student preparedness for industry roles.
  • Trained students on Medical Device Research, IRB process, and FDA regulatory requisites for industry-sponsored trials, ensuring compliance and fostering understanding of critical research protocols.
  • Facilitated the ‘Henrietta Lacks’ Research Conference—their First Formal visit to an academic Center in Arizona. Clinical Research Department and
  • Faculty and Clinical Research Department Signatory Authority.

Interim Administrative Director – IRB (BE SMITH Consultant)

City of Hope National Medical Center
04.2011 - 10.2011
  • April 2011 – Oct 2011
  • Apr 2011 – Oct 2011: Interim Administrative Director – IRB (BE SMITH Consultant)
  • Directed all research studies, including FDA regulated industry sponsored submissions, to internal and external Institutional Review Boards, ensuring adherence to ethical standards.
  • Leadership authority for continuous time-based review/analysis/summarization of adult & pediatric hematology/oncology Protocols [SWOG, NIH, COG, and PI – Initiated Studies] to include Informed Consent Forms [ICFs].
  • Managed thirteen direct reports, including protocol analysts, to ensure compliance and efficiency within Human Subject Protections Department.
  • Granted access to iMedris and iRIS digital software platform, facilitating efficient study submissions and compliance with CFR 21 Part 11 regulations.
  • Regular attendance at All internal IRB meetings.
  • Reported to the Institutional Administrator for All Campus Research.
  • Department Signatory Authority.

Clinical Research Director – Medical Devices

Regenesis Biomedical
12.2007 - 11.2010
  • Dec 2007 – Nov 2010: Clinical Research Director – Medical Devices
  • Led clinical research department in study conduct, protocol development, case report form design, and study execution.
  • Led the study monitoring visits.
  • Coordinated weekly project teleconferences with multiple VAMC Physician Principal Investigators to discuss study progress on 510 (k) Radiofrequency Devices (PROVANT).
  • Contributed to protocol IRB submissions to related VA facilities and collaborated with VA research staff and designated PIs to accelerate the approval process.
  • Contributed to budget proposals, development, and approvals with the appropriate VA research staff.
  • Participated firsthand with VAMC Research Counsel and VA Tech Transfer in collaborative design and development of the company’s first Device Master Clinical
  • Research and Device Agreement (CRADA) in June 2008. Reported to V.P. of Clinical.

Regional Clinical Research Associate

INC Research/Advanced Biologics Division
06.2006 - 12.2007
  • Jun 2006 – Dec 2007: Regional Clinical Research Associate
  • Monitored a Phase III Multi-centered Double-Blind Randomized C-DIFF Trial. (Infectious Disease).
  • Selected, approved, and managed investigative sites for study execution
  • Reviewed and ensured protocol maintenance and adherence to FDA regulations
  • Ongoing use of the Omnicomm Trialmaster System as the study tool for electronic data capture and remote monitoring; CFR 21 Part 11 compliant.
  • Maintained and shipped relevant source documents to sponsor for compliance
  • Investigative study sites covered the southwest US including the west coast and Vancouver, Canada.
  • Home Office Based/Contractor.

Facility Research Director – Medical Devices & Pharma

Banner Desert Hospital
03.2005 - 05.2006
  • Mar 2005 –May 2006: Facility Research Director – Medical Devices & Pharma
  • Oversaw campus-wide research studies requiring hospital and FDA IRB review and approval, while ensuring compliance and regulatory adherence.
  • Acted as primary clinical research liaison in IRB pre-review and feasibility meetings with intra-campus directors, hospital leadership, and research finance to assess board compliance and feasibility.
  • Ensured accuracy and proper formatting of all IRB submissions/documents; updated the campus on IRB policies and procedures.
  • Utilized IMedris, iRIS electronic protocol management system - CFR 21 Part 11 compliant.
  • Reported to the Hospital's Chief Operations Officer.

Lead Clinical Research Associate (CRA lll)

PPD
06.2004 - 03.2005
  • Jun 2004 –Mar 2005: Lead Clinical Research Associate (CRA lll)
  • Pediatric Vaccine Study for Infants with Respiratory Syncytial Virus (RSV).
  • Targeted Demographic: Native American Infants; Monitored Phase III pediatric vaccine trial on Shiprock Navajo Reservation, ensuring compliance and participant safety.
  • The largest and highest enrolling investigative site participating with the Johns Hopkins Navajo and White Apache Research Project Team; Co-sponsored by MedImmune.
  • Reported serious adverse events and adverse events to ensure participant safety and regulatory compliance.; timely and thorough source document review and Case Report Form review and Drug Accountability & Data Safety Monitoring.
  • Conducted routine site contact and reviewed regulatory documents from Indian Health Services, Johns Hopkins, Navajo Council, and the FDA to maintain study integrity.
  • Participated in investigator meetings and biweekly project teleconferences to facilitate communication and project alignment.

Project Director

Mountain Park Health Center
03.2002 - 05.2004
  • Mar 2002 –May 2004: Project Director
  • Functioned as the key Liaison between Department of Health and Human Services (DHHS)/Health Resource Services Administration
  • (HRSA) and the State of Arizona concerning a Public Health Policy grant proposal "To aid individuals in Arizona adversely affected by the mining of uranium and the testing of nuclear weapons through development of statewide programs designed to screen qualified people for cancer, and other diseases, as a means of early detection, prevention, and education."
  • Established statewide cancer and respiratory screening clinics to identify qualified individuals for early detection and prevention of cancer and other diseases.
  • The proposal supported a Cancer Screening Study Program entitled RESEP.
  • – Radiation Exposure Screening and Education Program; Under my leadership the following was established:
  • Managed an annual Health and Human Services budget of 350K.
  • Communicated effectively with Board Certified Internists, state Legislators, and Community Healthcare leaders to enhance collaboration and project outcomes.
  • Coordinated financial remuneration for impacted clients in partnership with the Department of Justice program to ensure support for affected individuals.
  • Engaged in direct communication with the VP of Programs to discuss project updates.
  • Earned NIOSH certification (National Institute of Safety and Health) to function as a Pulmonary Function Technician and conducted routine spirometry exam on targeted population with respiratory diseases.
  • B) situated in five Arizona Counties including the Navajo Reservation.
  • C) with a core mission ‘To aid individuals in Arizona adversely affected by the mining of uranium and the testing of nuclear weapons.'

Sr. Clinical Research Associate – Medical Devices

Medifacts International Inc.
03.2001 - 06.2002
  • Mar 2001 –Jun 2002: Sr. Clinical Research Associate – Medical Devices
  • Monitored a multi-centered study - A-HeFT, (African American)
  • Heart Failure Trial), entitled ‘A Phase II Placebo- Controlled Trial of Bidil, Added to Standard Therapy in African American Patients with Heart Failure and a Triple A Device Study.'
  • Monitored a multi-centered study - the X-Tract X-Sizer Device for Treatment of Thrombus and
  • Atherosclerosis in Coronary Interventions Protocol
  • Assured protocol compliance and timely reporting of Safety Data
  • Electronic Data Capture (EDC) training
  • Trained entry-level CRAs as directed by the Associate Director
  • Performed Investigational Product Accountability, ensuring proper handling and documentation of study products.
  • Participation in Investigator Meetings and bi-weekly study related teleconferences
  • Worked remotely from home office

Clinical Study Manager – Medical Devices

WL Gore & Associates
01.2001 - 06.2001
  • Jan 2001 –Jun 2001: Clinical Study Manager – Medical Devices
  • Study Manager for the Class III Abdominal Aortic Aneurysm Excluder Clinical Trial, a multi-centered investigative study.
  • Led clinical team for cardiovascular study with WL Gore and Associates Medical Devices Division, ensuring alignment with project goals.
  • Oversaw CRO clinical monitors and clinical study contracts, implementing a rescue plan to address outstanding investigative site issues and achieve complete data resolution for the pre-market approval submission.
  • Served as liaison between project team and Cleveland Clinic, facilitating communication and collaboration for trial success.
  • Reported to Clinical Director within Devices Division

Clinical Research Scientist

Dial Corporation
03.1999 - 01.2001
  • Mar. 1999 – Jan. 2001: Clinical Research Scientist
  • Direct oversight of all Dermatological Safety and Efficacy Studies reporting to the Toxicologist responsible for clinical studies.
  • Designed and executed clinical study parameters for the new ‘Dial Complete AntiBacterial Foaming Hand Wash.’
  • Protocol design for efficacy studies related to labeling claims for OTC products.
  • Co-authored Phase I pharmacokinetics protocol evaluating absorption rate of triclosan, conducted safety data analysis, and secured outside IRB approval.
  • Traveled throughout the US to outside testing centers to monitor/ audit the sites for GCP compliance, numerous skin patch test studies.
  • Conducted thorough analysis of final data sets to ensure accuracy and reliability. and Reporting
  • Managed clinical study budgets for three business franchises, overseeing accounts totaling $500,000.
  • Developed standard operating procedures for safety and efficacy clinical studies, ensuring compliance and consistency.
  • Collaborated with microbiologists and product development scientists on study variables and claims objectives.

Clinical Research Director – Medical Devices

OrthoLogic Corporation
08.1994 - 03.1999
  • Aug 1994 – Mar 1999: Clinical Research Director – Medical Devices
  • Directed Clinical Operations department overseeing multicentered orthopedic clinical trials for Class II, non-invasive Spina Logic medical device.
  • Key Clinical Team liaison to the Premarketing Group responsible for Submission of Trial
  • Data to FDA for Pre-market approval of the SpinaLogic device. FDA Approval granted in
  • Successful FDA audits of all Investigative Sites and related Sponsor Departments. No 483 citations
  • Collaborated with cross-functional teams, including engineers, to ensure device design and functionality from IDE through PMA development phase.
  • Implemented an internal Quality Assurance system for query tracking and resolution.
  • Trained Clinical Research Monitors and Project Specific Coordinators; co-monitored; handled hiring and firing responsibilities.
  • Drafted Annual Reports to the Food and Drug Administration (FDA) Division-Center for Devices and Radiological Health.
  • Drafted company policy and EN 540 compliant clinical protocol for CE compliance, leading to market release approval of Spinalogic Noninvasive Bone Growth Stimulator in August 2000, now distributed by Don Joy Orthopedics (DJO).

Clinical Research Specialist – Medical Devices

IMPRA Inc.
08.1992 - 06.1994
  • Aug 1992 –Jun 1994: Clinical Research Specialist – Medical Devices
  • Oversaw human clinical trials and animal studies, ensuring adherence to research protocols and regulatory standards.
  • Developed protocols for vascular post-market surveillance studies, collaborating with the Director of Clinical and Regulatory Affairs.
  • Verified compliance with FDA rulings for post-market surveillance, mitigating risks associated with regulatory non-compliance.
  • Selected as the company representative for HIMA’s (Health Industry Manufacturer’s
  • Association) Vascular Graft Force which hosted regular meetings in Washington, DC.
  • The Task Force established a venue for graft manufacturers to collaborate the development of new industry standards.

Sr. Clinical Research Coordinator – Medical Devices

Arizona Heart Institute
07.1989 - 08.1992
  • Jul 1989 –Aug 1992: Sr. Clinical Research Coordinator – Medical Devices
  • Coordinated clinical trial operations for cardiovascular studies at a leading heart institute.
  • Coordinated logistics and operations for Coronary Stent PMA study in support of the Principal Investigator.
  • Managed patient recruitment and retention strategies for multiple research projects.
  • Developed and maintained study documentation in compliance with regulatory standards.

Clinical Research Data Coordinator - Research Assistant

Arizona Cancer Center – University Health Sciences Center
06.1986 - 07.1989
  • Jun 1986 – Jul 1989 Clinical Research Data Coordinator - Research Assistant
  • Coordinated data management and pharmacological data collection in a multidisciplinary hematology and oncology clinic under Principal Investigator oncologists and scientists.
  • Supported principal investigator by collecting data and completing case report forms for genitourinary cancer studies.
  • Facilitated preparation of Phase I and II studies for university IRB submission and approval.
  • Trial participation focused on Melanoma studies sponsored by Burroughs Wellcome; Basal & Squamous
  • Cell – Skin Cancers; Myelodysplasia and Genitourinary Protocols supported and or sponsored by Southwest Oncology Group (SWOG), and McNeil Pharmaceuticals
  • Mandatory Attendance of Bi-weekly Tumor Boards.
  • Reported to Department Lead Data Manager and study related PI.

Education

Certified Clinical Research Professional (CCRP) -

SoCRA
09-2026

Continuing Education – 11th Annual ABRC - Flinn Research Conference - Conference Focus: Grant Awardees from the ABRC and Flinn Foundation Showcase Research Advances in a Variety of Fields

Arizona Dept. of Health Services; FLINN Foundation; College of Medicine Phoenix Research Office. University of Arizona Health Sciences
Phoenix, Arizona
05-2026

Harvard Medical School, Emeritus Executive Studies; Clinical Development Strategies: Beyond Clinical Trials - Emeritus Executive Studies; Clinical Development Strategies: Beyond Clinical Trials

Harvard Medical School - Exec Studies Certificate
12-2025

Continuing Education – Transformative Endovascular Decisions: A Meeting of the Experts in the Treatment of Vascular Disease to Discuss Innovations in the Field -

The Phoenician
Scottsdale, Arizona
03-2023

Master of Laws - Health Law, Policy, and Ethics

Hofstra University, Maurice A. Deane Law School
Hempstead, New York
08-2022

Continuing Education – American Health Law Association/Health Law: “What Types of Consents are Required for Hospitalizations?” -

American Health Law Association
02-2022

Continuing Education – Clinical Research Professional/Health Law: “Disproportionate Impact of COVID-19 on Minority Populations" -

American Health Law Association
01-2021

Continuing Education – Clinical Research Professional: “Elevating the Clinical Research Profession and Transforming the World of Clinical Research,” -

SoCRA
09-2020

Executive Juris Doctor - Purdue Global/Purdue University -

Purdue Global/Purdue University
01-2008

Bachelor of Science -

University of Arizona
Tucson, AZ

Skills

  • Clinical research
  • Clinical trial management
  • Clinical Research Contracts/Negotiations
  • Clinical ethics
  • Statistical methods
  • Project oversight
  • Curriculum development

Affiliations

  • Parks, Recreation, Golf, and Double Butte Advisory Board; City of Tempe, Arizona, 2024-01-01
  • Marquis Who’s Who (Est. 1898, Research and Education), Honored Listee, 2024-05-15
  • NCBW, Phoenix Chapter, Second Vice President of Finance and Fund-Raising, 2021-01-01, 2022-12-31

Certifications And Registrations

  • Certified Clinical Research Professional (SoCRA), SoCRA, 22525, 2008-02-01, 2027-05-01, active
  • Teaching Certificate (Substitute Instructor/Guest Teacher), AZ Dept. of Education, 4452478, 2031-11-05, active, AZ, US
  • Fingerprint Clearance, AZ State Department of Public Safety, 2023PO4439, IVP 0220233, 2029-03-07, active, AZ, US
  • Professional Consultant Services – Clinical Research & Educational Consulting, Legacy Clinical Trials, 438449, 27-4455812, unknown

Awards And Appointments

  • Arizona Bioethics Board – Member, Arizona Bioethics Board, 2025-01-01, 2026-12-31, AZ, US
  • Honored Listee, Marquis Who’s Who (Est. 1898, Research and Education), 2024-01-01
  • Special Recognition Award Program Selectee – Poster Presentation, Society of Clinical Research Annual Conference, 2021-09-01, 2021-09-30
  • Acting Second Vice President of Funds and Fund-Raising Chair, National Coalition of 100 Black Women, Phoenix Chapter, 2020-01-01, 2021-12-31, Phoenix, AZ, US
  • Committee on Accreditation for Academic Programs in Clinical Research – Board Appointment, Committee on Accreditation for Academic Programs in Clinical Research, 2018-01-01, 2019-12-31
  • National Health Award / NAACP, NAACP, 2008-01-01, 2009-12-31

Publications And Papers

The Academic Advantage - Benefits of TrialMaster EDC in Higher Learning for Clinical Research Students, Innovation Forum 2013; Omnicomm, Fort Lauderdale, FL, US, 2013-11-14, 2013-11-15, Culturally Competent Clinical Trials – A Continued Commitment to Human Subject Protection. Embracing Change-Clinical Research in the 21st Century., Arizona State University, Tempe, AZ, US, 2013-09-21, 2013-09-21, Combined Magnetic Fields Accelerate Primary Spine Fusion: A Prospective, Double Blind, Randomized, placebo Controlled Clinical Study, International Conference on Bioelectromagnetism, Bled, SI, 2000-10-10, 2000-10-10, Combined Magnetic Fields Accelerate Primary Spine Fusion in Women, AAOS; Poster Board Presentation, 2000-03-01, 2000-03-31, Only month/year provided (March 2000)., Chronic Iliac Occlusions: Intraluminal Stents are the Treatment of Choice, Barcelona, ES, 1992-08-30, 1992-09-03, Brachial Versus Femoral Approach to Intracoronary Stent Placement: A Comparison of Efficacy and Complications, Phoenix, AZ, US, 1992-04-12, 1992-04-16, Stent Implantation for Stenosis in Saphenous Vein Bypass Grafts, Angio 91, Congress International d’Angiologie, Paris, FR, 1991-04-12, 1991-04-14, Stent Implantation for Stenosis in Saphenous Vein Bypass Grafts, Cardiovascular Science and Technology: Basic and Applied II, Louisville, KY, US, 1990-11-30, 1990-11-30, Application of Endovascular Stents in the Abdominal Aorta, Cardiovascular Science and Technology. Basic and Applied II, Louisville, KY, US, 1990-11-30, 1990-11-30, Pharmacokinetics (PK) and Phase I Clinical Trial of the Arylmethylaminopropanediol (AMAP) Crisnatol (CRIS, BW A77OU), A Highly Soluble Drug Which Distributes into the CSF, Proceeding, American Association of Cancer Research, US, 1988-01-01, 1988-12-31, Only year provided (1988)., Partners with Key Voter Registration State Leadership in a Virtual Q&A, ‘Reclaiming Our Voices Through Our Vote’, NCBW 100 Phoenix Public Policy Committee, Phoenix, AZ, US, 2020-06-23, A Pilot Study: A Single Center Controlled Feasibility Study Comparing Standardized Basic Wound Care to Provant Wound Therapy System as an Adjunct to Standardized Basic Wound Care, Regenesis Biomedical, 2008-01-01, Only year provided (2008)., From the Goodness of the Heart – Spotlight on Dr. Glenn Waterkotte, Banner Health Research Institute Newsletter, 2005-12-28, Advisory Legislative Support Letter to the Governor of Arizona and the National Research Council: RE: Inclusion of Mohave County into the Radiation Exposure Compensation Act, AZ, US, 2004-02-01, Month/year provided (February 2004)., A Phase I Protocol, Pharmacokinetics Study Evaluating the Absorption Rate of Triclosan – the Dial Corporation, 2000-01-01, Year provided as 2000; exact month/day not provided., A Protected Class, An Unprotected Condition, and A Biomarker – A Method/Formula for Increased Diversity in Clinical Trials for the African American Subject with Benign Ethnic Neutropenia (BEN), American Journal of Law and Medicine, Cambridge University Press, 2023-06-01, https://doi.org/10.1017/amj.2023.15, Culturally Competent Clinical Trials—A Continued Commitment to Human Subject Protection, MEDCRAVE ONLINE JOURNAL, 2015-04-21, Culturally Competent Clinical Trials—A Continued Commitment to Human Subject Protection, SoCRA Source Journal, 2013-11-01, Only month/year provided (November 2013)., Combined Magnetic Fields Accelerate and Increase Spine Fusion: A Double-Blind Randomized, Placebo Controlled Study, Spine, An International Journal for the Study of the Spine, 2002-07-01, Palmaz-Schatz Stent Implantation in Stenosed Saphenous Vein Grafts: Clinical and Angiographic Follow-up, American Heart Journal, 1992-01-01, Only year provided (1992)., Clinical Experience with the Palmaz-Schatz Coronary Stent: Initial Results of a Multicenter Study in the United States, Circulation, 1991-01-01, Only year provided (1991).

Lectures And Speaker Engagements

  • Reclaiming Our Voices Through Our Vote (Virtual Q&A), Moderator, National Coalition of 100 Black Women, Inc. Phoenix Metropolitan Chapter, Phoenix, AZ, US, 2020-06-28, 2020-06-28, Zoom Virtual Teleconference Q & A; Arizona Secretary of State Katie Hobbs and Adrian Fontes.
  • Health Talk Radio Broadcast – Interview with Maricopa County Public Health Department Director, Dr. Bob England, Co-Host, KXXT 1010 AM, 2018-01-06, 2018-01-06
  • Town Hall Meeting—Vision, Policies and Procedures (Introduction of Mr. Paul Penzone), Speaker, Phoenix, AZ, US, 2017-10-10, 2017-10-10
  • Health Talk Radio Broadcast – Co-Host (seasonal live co-host), Co-Host, KXXT 1010 AM, 2015-05-01, 2017-10-31, May 2015 – October 2017.
  • Introduction to Clinical Trials Workshop; Radiation Therapy Student Lecture, Speaker, Maricopa Community Colleges – Gateway Community College, 2016-03-10, 2016-03-10
  • Blurred Lines – Making Ethical Decisions in an Unethical World; Henrietta Lacks Family Presentation, Moderator, Clinical Research Symposium at Gate Way Community College, 2014-03-25, 2014-03-25
  • The Legal Anatomy of the Clinical Research Process; Radiation Therapy Cohorts, Speaker, Health Sciences Division, Gateways Community College, 2013-02-14, 2013-02-14
  • Introduction to Clinical Trials, Speaker, Maricopa Community Colleges – Gateway Community College, 2012-11-19, 2012-11-19
  • Clinical Trials – A Basic Overview, Speaker, Regenesis Biomedical Corporate Training, Carefree, AZ, US, 2008-04-02, 2008-04-02
  • Campus Research Activity Overview; Management Team Meeting, Speaker, Banner Desert Medical Center, Mesa, AZ, US, 2006-03-22, 2006-03-22
  • Radiation Exposure Screening and Education Program – Overview and Qualifications, Speaker, The Navajo Nation Environmental Protection Agency Meeting, Fort Defiance, US, 2004-01-01, 2004-01-31, January 2004; day not provided.
  • Radiation Exposure Screening and Education Program- Awareness Training, Speaker, Navajo Nation EPA Meeting, Flagstaff, AZ, US, 2003-07-31, 2003-07-31
  • GCP Overview-Sponsor Responsibilities; Leadership Meeting, Speaker, Dial Corporation, Scottsdale, AZ, US, 2000-03-22, 2000-03-22

Addresses

unknown, US

Personal Information

Title: Clinical Research Professional

Timeline

Contractor; Life Sciences, Research and Mathematics Instruction

Greater Metropolitan College Preparatory Charter Schools
01.2017 - 12.2025

Regional Based CRA

PRA Health Sciences
05.2016 - 02.2017

Consultant Clinical Research Coordinator – Medical Devices

Valley Urogynecology Associates
05.2015 - 01.2016

Faculty/Lecturer

GateWay Community College
01.2015 - 12.2016

Clinical Research Program Director/Faculty

Maricopa Community Colleges
01.2013 - 12.2016

Clinical Research Director and Educator

GateWay Community College
01.2012 - 05.2016

Interim Administrative Director – IRB (BE SMITH Consultant)

City of Hope National Medical Center
04.2011 - 10.2011

Clinical Research Director – Medical Devices

Regenesis Biomedical
12.2007 - 11.2010

Regional Clinical Research Associate

INC Research/Advanced Biologics Division
06.2006 - 12.2007

Facility Research Director – Medical Devices & Pharma

Banner Desert Hospital
03.2005 - 05.2006

Lead Clinical Research Associate (CRA lll)

PPD
06.2004 - 03.2005

Project Director

Mountain Park Health Center
03.2002 - 05.2004

Sr. Clinical Research Associate – Medical Devices

Medifacts International Inc.
03.2001 - 06.2002

Clinical Study Manager – Medical Devices

WL Gore & Associates
01.2001 - 06.2001

Clinical Research Scientist

Dial Corporation
03.1999 - 01.2001

Clinical Research Director – Medical Devices

OrthoLogic Corporation
08.1994 - 03.1999

Clinical Research Specialist – Medical Devices

IMPRA Inc.
08.1992 - 06.1994

Sr. Clinical Research Coordinator – Medical Devices

Arizona Heart Institute
07.1989 - 08.1992

Clinical Research Data Coordinator - Research Assistant

Arizona Cancer Center – University Health Sciences Center
06.1986 - 07.1989

Certified Clinical Research Professional (CCRP) -

SoCRA

Continuing Education – 11th Annual ABRC - Flinn Research Conference - Conference Focus: Grant Awardees from the ABRC and Flinn Foundation Showcase Research Advances in a Variety of Fields

Arizona Dept. of Health Services; FLINN Foundation; College of Medicine Phoenix Research Office. University of Arizona Health Sciences

Harvard Medical School, Emeritus Executive Studies; Clinical Development Strategies: Beyond Clinical Trials - Emeritus Executive Studies; Clinical Development Strategies: Beyond Clinical Trials

Harvard Medical School - Exec Studies Certificate

Continuing Education – Transformative Endovascular Decisions: A Meeting of the Experts in the Treatment of Vascular Disease to Discuss Innovations in the Field -

The Phoenician

Master of Laws - Health Law, Policy, and Ethics

Hofstra University, Maurice A. Deane Law School

Continuing Education – American Health Law Association/Health Law: “What Types of Consents are Required for Hospitalizations?” -

American Health Law Association

Continuing Education – Clinical Research Professional/Health Law: “Disproportionate Impact of COVID-19 on Minority Populations" -

American Health Law Association

Continuing Education – Clinical Research Professional: “Elevating the Clinical Research Profession and Transforming the World of Clinical Research,” -

SoCRA

Executive Juris Doctor - Purdue Global/Purdue University -

Purdue Global/Purdue University

Bachelor of Science -

University of Arizona
Regina Ponder